Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
AE, began, Biogen, childbearing, confirmatory, Eastern, exact, franchise, identification, retroactive, substance, Thursday, topline, zuranolone, Zurzuvae
Removed:
appeal, biochemical, body, composition, Department, enrollment, hematocrit, LFI, notification, panel, recruiting, regain
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view